Evaluation of recombinant human tumor necrosis factor by cell electrophoresis. II. In vivo effect of recombinant human tumor necrosis factor on cell populations and natural killer-activity in spleen of tumor-bearing mice
✍ Scribed by Dr. Joachim Rychly; Eberhard Knippel; Jürgen Milleck; Wolfgang Schütt; Horst Nizze; Burghard Kramp; Horst Klinkmann
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 533 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The ability of recombinant human tumor necrosis factor (rH-TNF-alpha) to induce regression of sarcoma 180 in vivo was evaluated. The tumor was cured by TNF in the course of 4 weeks. TNF inhibited proliferation of sarcoma 180 cells in vitro, which suggests a direct effect of TNF on tumor cells in viv
Programmed cell death contributes to the morbidity and mortality of several neurological disorders including stroke, Alzheimer's disease and human immunodeficiency virus (HIV)-associated dementia. Patients with HIV dementia show evidence of programmed cell death in brain. In vitro data demonstrates
## Abstract The effects of recombinant human tumor necrosis factor‐α (rhTNF‐α) on inward rectifier potassium [K(IR)] currents and on cell morphology have been studied in cultured human oligodendrocytes. Cell‐attached patches were used to isolate and record unitary currents through an inward rectifi
## Abstract Tumor necrosis factor α (TNF) exhibits cytotoxic activity on some solid tumors and has been reported to be synergistic with topoisomerase‐II‐targeted antineoplastic agents. A wide range of TNF concentrations (from 10 to 10,000 U/ml) was tested in 9 human lung cancer cell lines (5 small‐